Nolla Health Launches First AI System to Issue Acne Prescriptions Autonomously in Utah

Nolla Health Breaks Ground with Autonomous AI Prescriptions

Nolla Health, a New York-based healthcare startup, has launched the first AI system authorized to issue initial prescriptions autonomously in the United States1

1

. The pilot program, approved by Utah regulators, allows the company's AI to analyze facial scans and patient data to prescribe acne treatment without prior physician approval for each case2

2

. This marks a significant shift from conventional telehealth services where medical professionals make final prescribing decisions.

The Nolla Derm app targets Utah residents aged 18 and older with mild-to-moderate acne1

1

. Users complete a 10- to 15-minute questionnaire and submit facial scans, enabling the AI system to autonomously prescribe from eight different skin treatments within minutes1

1

2

2

. The service costs $4.99 per month and represents the first instance of AI issuing initial prescriptions rather than simply renewing existing medications1

1

.

Gradual Reduction in Physician Oversight

The autonomous prescription system will roll out through three distinct stages with progressively reduced physician oversight2

2

. Initially, two physicians will approve each AI-generated acne prescription for the first 100 patients1

1

. During the second phase covering up to 500 patients, the AI system autonomously prescribes while physicians review prescriptions retrospectively each day2

2

. In the final stage, doctors will review only a sample of at least 10 percent of prescriptions monthly, plus every case involving escalation or side effects1

1

.

This phased approach allows Utah's Office of Artificial Intelligence Policy to evaluate autonomous medical decision-making under the state's AI regulatory framework2

2

. The pilot program was developed specifically to test new AI applications in healthcare while maintaining patient safety through structured oversight mechanisms.

Machine-Learning Models Drive Treatment Decisions

Nolla Health's platform employs multimodal machine-learning models, including vision transformers, to identify patterns across facial scans and patient information2

2

. The company's broader healthcare systems have been trained on more than 3 million labeled clinical cases2

2

. However, the AI cannot create its own treatment regimens or freely choose among all prescription drugs.

Dr. Zaid Fadul, Nolla Health's chief medical adviser, explained that the AI can only select from a short list of physician-approved topical treatments2

2

. When the system cannot confidently select a treatment or when patients fall outside predefined parameters, it immediately hands the case to a licensed physician1

1

2

2

. Licensed clinicians agree with the system's treatment recommendations in more than 96 percent of real-world cases, with disagreements typically involving minor adjustments like changing medication strength2

2

.

Implications for Healthcare and Future Expansion

This development represents a fundamental departure from traditional telehealth models where software assists clinicians but humans make final decisions. Nolla Health's approach allows the AI system to make prescribing decisions itself within predefined limits2

2

. The company positions the pilot as complementing rather than replacing physicians, freeing dermatologists to focus on complex, high-risk patients while AI handles routine, low-acuity cases1

1

.

The Nolla Derm app has already been downloaded more than 175,000 times across 44 states, though autonomous initial prescribing remains limited to eligible adults in Utah2

2

. After receiving prescriptions, patients can choose home delivery or pharmacy pickup, with the app using daily skin scans to track treatment progress and monthly plan reviews2

2

.

Fadul indicated that acne serves as a test case, with plans to expand to other common conditions that are well understood, easy to assess remotely, and treated with medications having strong safety profiles3

3

. Several other healthcare companies are experimenting with AI-generated prescriptions in Utah, which began allowing AI systems to renew certain medications earlier this year1

1

. The success of this pilot program could establish precedents for autonomous medical decision-making and shape how AI regulatory frameworks evolve across healthcare systems nationwide.